.jpg)
How PureTech’s lung fibrosis drug stacks up against the competition
PureTech Health’s tweaked form of Roche’s lung fibrosis drug Esbriet slowed lung function decline by a greater degree than Esbriet itself, with comparable safety, the company said Tuesday. On a cross ...
PureTech Health’s tweaked form of Roche’s lung fibrosis drug Esbriet slowed lung function decline by a greater degree than Esbriet itself, with comparable safety, the company said Tuesday.
On a cross ...
